Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 194 (8), 1032-9

Immunogenicity and Reactogenicity of 1 Versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine-Naive 5-8-year-old Children

Affiliations
Randomized Controlled Trial

Immunogenicity and Reactogenicity of 1 Versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine-Naive 5-8-year-old Children

Kathleen M Neuzil et al. J Infect Dis.

Abstract

Background: Two doses of trivalent inactivated influenza vaccine (TIV) are recommended for children <9 years old receiving vaccine for the first time, but compliance is suboptimal. This study assessed the need for a second dose of TIV in this age group.

Methods: In this prospective, open-label study, 232 influenza vaccine-naive 5-8-year-olds enrolled in a health maintenance organization received 2 doses of TIV in fall 2004. Serum for antibody titer measurement was obtained at 3 time points (n = 222). Parents completed diaries for 5 days.

Results: Both doses of vaccine were well tolerated. The strongest predictor of a protective antibody response (> or =1 : 40) after 1 dose of TIV was baseline seropositive status. In multivariate analysis adjusting for age, sex, and baseline serostatus, the proportion of children with protective antibody responses was significantly higher after 2 doses than after 1 dose of TIV for each antigen (P < .001, for A/H1N1; P = .01, for A/H3N2; P < .001, for B). Age and sex were not independently predictive of a protective antibody response. Over one-third of children had antibody responses <1:40 for the type B vaccine component, even after 2 doses.

Conclusions: The present study supports the need for 2 doses of TIV in 5-8-year-olds receiving TIV for the first time. Efforts to increase compliance with the 2-dose recommendation are warranted.

Comment in

Similar articles

See all similar articles

Cited by 52 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback